RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 140 filers reported holding RIGEL PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $47 | -99.7% | 31,538 | +109.2% | 0.00% | +100.0% |
| Q3 2022 | $18,000 | -87.7% | 15,078 | -55.3% | 0.00% | -80.0% |
| Q2 2021 | $146,000 | +27.0% | 33,711 | 0.0% | 0.01% | +25.0% |
| Q1 2021 | $115,000 | -11.5% | 33,711 | -9.3% | 0.00% | -20.0% |
| Q4 2020 | $130,000 | +3.2% | 37,180 | -29.2% | 0.01% | -16.7% |
| Q3 2020 | $126,000 | +31.2% | 52,478 | 0.0% | 0.01% | +20.0% |
| Q2 2020 | $96,000 | +433.3% | 52,478 | +359.7% | 0.01% | +400.0% |
| Q1 2020 | $18,000 | -25.0% | 11,416 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $24,000 | – | 11,416 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 9,105,691 | $30,140,000 | 5.99% |
| Sio Capital Management, LLC | 1,888,181 | $6,250,000 | 3.50% |
| DAFNA Capital Management LLC | 473,478 | $1,567,000 | 1.32% |
| Cormorant Asset Management, LP | 2,000,000 | $6,620,000 | 0.96% |
| Ghost Tree Capital, LLC | 1,100,000 | $3,641,000 | 0.68% |
| Rhenman & Partners Asset Management AB | 1,282,000 | $4,243,000 | 0.67% |
| Palo Alto Investors LP | 4,254,623 | $14,083,000 | 0.67% |
| NEA Management Company, LLC | 3,243,150 | $10,375,000 | 0.36% |
| Telemetry Investments, L.L.C. | 170,000 | $563,000 | 0.25% |
| NJ State Employees Deferred Compensation Plan | 355,000 | $1,175,000 | 0.22% |